Q4 2023 Holdings
Filed 2024-02-13 | 70 holdings | $374.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $24.4M | 2,169,116 | 6.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $23.7M | 1,094,494 | 6.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $17.4M | 313,604 | 4.6% |
| Merus N V | COM | N5749R100 | $13.8M | 501,806 | 3.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $13.6M | 322,015 | 3.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $12.2M | 862,815 | 3.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $11.8M | 513,681 | 3.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $10.7M | 1,020,214 | 2.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $10.3M | 253,948 | 2.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $10.2M | 450,706 | 2.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $10.1M | 167,851 | 2.7% |
| Argenx SE | CALL | 04016X901 | $10.1M | 26,484 | 2.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $9.7M | 89,016 | 2.6% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $9.6M | 61,011 | 2.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $8.9M | 249,575 | 2.4% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $8.8M | 15,067 | 2.3% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $8.8M | 1,790,182 | 2.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $8.4M | 2,594,536 | 2.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $8.2M | 378,766 | 2.2% |
| Teva Pharmaceutical Inds LTD | CALL | 881624909 | $7.3M | 701,597 | 2.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $7.2M | 125,429 | 1.9% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $6.8M | 108,911 | 1.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $6.3M | 104,650 | 1.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $6.2M | 856,952 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.4M | 173,579 | 1.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.2M | 423,174 | 1.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $4.8M | 111,354 | 1.3% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.7M | 218,319 | 1.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $4.7M | 20,444 | 1.3% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $4.7M | 9,921 | 1.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $4.7M | 85,382 | 1.3% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.7M | 246,178 | 1.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.6M | 408,257 | 1.2% |
| Acelyrin Inc | COM | 00445A100 | $4.4M | 587,373 | 1.2% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.3M | 182,258 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $3.9M | 281,287 | 1.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.6M | 783,172 | 1.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $3.6M | 567,211 | 0.9% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $3.4M | 898,196 | 0.9% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $3.2M | 183,102 | 0.9% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $3.0M | 907,152 | 0.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.0M | 22,500 | 0.8% |
| Jasper Therapeutics Inc | CALL | 471871903 | $2.9M | 3,707,110 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.9M | 451,375 | 0.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $2.8M | 607,100 | 0.7% |
| Morphosys AG | CALL | 617760902 | $2.7M | 277,485 | 0.7% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $2.5M | 376,573 | 0.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.2M | 95,732 | 0.6% |
| AC Immune SA(ACIU) | SHS | H00263105 | $2.2M | 434,588 | 0.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.0M | 24,111 | 0.5% |